Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

OPRX

OptimizeRx Corp

May 02 • 04:00PM ET

10.70

Dollar change +0.28
Percentage change 2.69	%

Healthcare • Health Information Services • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO VTWO VHT AVUV DFAS IWC AVSC

Index	RUT	P/E	-	EPS (ttm)	-1.02	Insider Own	12.18%	Shs Outstand	18.16M	Perf Week	21.59%
Market Cap	194.53M	Forward P/E	18.66	EPS next Y	0.57	Insider Trans	-0.18%	Shs Float	15.97M	Perf Month	-4.21%
Income	-17.57M	PEG	-	EPS next Q	-0.13	Inst Own	71.87%	Short Float	3.92%	Perf Quarter	-27.65%
Sales	71.52M	P/S	2.72	EPS this Y	44.51%	Inst Trans	-10.24%	Short Ratio	4.68	Perf Half Y	32.75%
Book/sh	6.97	P/B	1.54	EPS next Y	52.60%	ROA	-11.05%	Short Interest	0.63M	Perf Year	-27.46%
Cash/sh	0.76	P/C	14.05	EPS next 5Y	11.50%	ROE	-13.90%	52W Range	6.92 - 16.65	Perf YTD	-25.23%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-10.90%	52W High	-35.72%	Beta	1.25
Dividend TTM	-	Quick Ratio	3.04	Sales past 5Y	30.00%	Gross Margin	56.62%	52W Low	54.62%	ATR (14)	0.63
Dividend Ex-Date	-	Current Ratio	3.04	EPS Y/Y TTM	-60.13%	Oper. Margin	-18.49%	RSI (14)	50.44	Volatility	5.52% 5.60%
Employees	136	Debt/Eq	0.29	Sales Y/Y TTM	14.53%	Profit Margin	-24.56%	Recom	1.29	Target Price	16.17
Option/Short	Yes / Yes	LT Debt/Eq	0.27	EPS Q/Q	-1094.24%	Payout	-	Rel Volume	0.66	Prev Close	10.42
Sales Surprise	1.62%	EPS Surprise	-32.22%	Sales Q/Q	44.34%	Earnings	May 14 AMC	Avg Volume	133.86K	Price	10.70
SMA20	5.42%	SMA50	-13.37%	SMA200	-5.62%	Trades		Volume	88,211	Change	2.69%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-04-24	Initiated	JMP Securities	Mkt Outperform	$15
Jan-03-24	Initiated	Barclays	Equal Weight	$15
Feb-02-23	Resumed	B. Riley Securities	Buy	$30
Nov-01-22	Initiated	Stifel	Buy	$19
Jul-15-22	Initiated	SVB Leerink	Outperform	$38
Oct-18-21	Resumed	B. Riley Securities	Buy	$102
Apr-13-21	Initiated	RBC Capital Mkts	Outperform	$65
Jan-03-19	Initiated	William Blair	Outperform

Apr-26-24 07:30AM	OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET (GlobeNewswire) +15.00%
Apr-23-24 09:35AM	After Plunging -22.84% in 4 Weeks, Here's Why the Trend Might Reverse for OptimizeRx (OPRX) (Zacks)
Apr-22-24 09:35AM	Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX) (Zacks)
Apr-18-24 07:30AM	OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report (GlobeNewswire)
Apr-16-24 07:00AM	OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
07:30AM	Loading…
Apr-11-24 07:30AM	OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row (GlobeNewswire)
Apr-06-24 06:00AM	7 Top Undervalued Stocks Primed for a Multibagger Recovery (InvestorPlace)
Apr-01-24 03:02PM	OptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call Transcript (Insider Monkey) -6.01%
Mar-28-24 09:54PM	OPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023 (InvestorPlace)
Mar-25-24 07:30AM	OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET (GlobeNewswire)
Mar-11-24 04:30PM	OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023 (GlobeNewswire)
Mar-04-24 03:51PM	OptimizeRx Powers Walmart's 'Specialty Pharmacies of the Community' Outreach Effort (GlobeNewswire)
Feb-21-24 07:30AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-25-24 07:30AM	OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape (GlobeNewswire)
Jan-09-24 07:30AM	OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update (GlobeNewswire) +13.85%
06:19AM	Loading…
Dec-26-23 06:19AM	Should You Exit OptimizeRx Corp. (OPRX)? (Insider Monkey)
Dec-18-23 07:30AM	OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco (GlobeNewswire) +5.98%
Dec-11-23 12:00PM	OptimizeRx Corp. (OPRX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Dec-06-23 09:55AM	Wall Street Analysts Predict a 41.25% Upside in OptimizeRx Corp. (OPRX): Here's What You Should Know (Zacks)
Nov-21-23 12:20PM	Why OptimizeRx Corp. (OPRX) Might be Well Poised for a Surge (Zacks)
Nov-20-23 09:55AM	How Much Upside is Left in OptimizeRx Corp. (OPRX)? Wall Street Analysts Think 47.72% (Zacks)
Nov-13-23 11:38AM	OptimizeRx Corporation (NASDAQ:OPRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 02:17AM	Q3 2023 OPTIMIZERx Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-06-23 08:17AM	OptimizeRx Corp (OPRX) Reports Q3 2023 Earnings, Raises 2023 Guidance and Introduces 2024 Guidance (GuruFocus.com) +15.31%
07:00AM	OptimizeRx Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-30-23 10:00AM	OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-25-23 07:30AM	OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET (GlobeNewswire) -5.14%
Oct-13-23 03:59AM	OptimizeRx Corp. (OPRX) Surges 13.0%: Is This an Indication of Further Gains? (Zacks) +5.07%
Oct-12-23 07:00AM	OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers (GlobeNewswire) +13.01%
Sep-26-23 08:00AM	OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform (GlobeNewswire)
08:00AM	Loading…
Aug-24-23 08:00AM	OptimizeRx Expands AI Powered Omnichannel Platform (GlobeNewswire)
Aug-14-23 04:01PM	OptimizeRx Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-10-23 06:57AM	Positive Signs As Multiple Insiders Buy OptimizeRx Stock (Simply Wall St.)
Jul-31-23 08:01AM	OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET (GlobeNewswire)
Jun-30-23 10:52AM	OptimizeRx Corporation (NASDAQ:OPRX) is a favorite amongst institutional investors who own 85% (Simply Wall St.)
Jun-20-23 08:00AM	LifeMD Appoints William J. Febbo to its Board of Directors (GlobeNewswire)
May-24-23 07:30AM	OptimizeRxs CEO Provides 2023 Midyear Strategic Update (GlobeNewswire) +11.70%
May-23-23 07:51PM	Down More Than 50%: These 3 Beaten-Down Stocks Could Stage a Strong Rebound, Analysts Say (TipRanks)
May-18-23 09:00AM	Revenues Tell The Story For OptimizeRx Corporation (NASDAQ:OPRX) (Simply Wall St.)
08:01AM	OptimizeRxs Karina Castagna Named One of the 2023 PM360 ELITE 100 (GlobeNewswire)
May-15-23 08:00AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-10-23 05:15PM	OptimizeRx Corp. (OPRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	OptimizeRx Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-04-23 06:38AM	Investing in OptimizeRx (NASDAQ:OPRX) five years ago would have delivered you a 114% gain (Simply Wall St.)
May-02-23 08:00AM	Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance (GlobeNewswire)
Apr-26-23 08:00AM	OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET (GlobeNewswire)
Apr-17-23 10:38AM	Should You Think About Buying OptimizeRx Corporation (NASDAQ:OPRX) Now? (Simply Wall St.)
Apr-04-23 08:01AM	OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report (GlobeNewswire)
Apr-02-23 08:55AM	A Look At The Intrinsic Value Of OptimizeRx Corporation (NASDAQ:OPRX) (Simply Wall St.)
Mar-29-23 09:20AM	Financial Times Ranks OptimizeRx Amongst The Americas Fastest Growing Companies for the Fourth Consecutive Year (GlobeNewswire)
Mar-15-23 03:18AM	OptimizeRx Corp. (OPRX) Soars 7.2%: Is Further Upside Left in the Stock? (Zacks)
Mar-14-23 07:30AM	OptimizeRx Authorizes $15 Million Share Repurchase Program (GlobeNewswire) +7.18%
Mar-12-23 08:40AM	Some OptimizeRx Corporation (NASDAQ:OPRX) Analysts Just Made A Major Cut To Next Year's Estimates (Simply Wall St.)
Mar-11-23 07:13AM	Analysts Have Lowered Expectations For OptimizeRx Corporation (NASDAQ:OPRX) After Its Latest Results (Simply Wall St.)
Mar-10-23 02:39AM	OptimizeRx Corporation (NASDAQ:OPRX) Q4 2022 Earnings Call Transcript (Insider Monkey) -8.78%
Mar-09-23 09:06AM	Q4 2022 OPTIMIZERx Corp Earnings Call (Thomson Reuters StreetEvents) -11.64%
08:01AM	OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients (GlobeNewswire)
Mar-08-23 05:25PM	OptimizeRx Corp. (OPRX) Q4 Earnings Beat Estimates (Zacks)
04:01PM	OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-03-23 06:56PM	Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
05:02AM	Great news for OptimizeRx Corporation (NASDAQ:OPRX): Insiders acquired stock in large numbers last year (Simply Wall St.)
Mar-02-23 10:54AM	Should You Buy OptimizeRx (OPRX) Ahead of Earnings? (Zacks)
10:00AM	Oracle (ORCL) Earnings Expected to Grow: Should You Buy? (Zacks)
Feb-23-23 08:00AM	OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET (GlobeNewswire) +5.15%
Feb-16-23 10:01AM	OptimizeRx Corp. (OPRX) to Report Q4 Results: Wall Street Expects Earnings Growth (Zacks)
Feb-09-23 08:30AM	OptimizeRxs Karina Castagna Named to MM+Ms 40 Under 40 List of the Medical Marketing Industrys Brightest Young Stars (GlobeNewswire)
Jan-21-23 09:12AM	With 86% institutional ownership, OptimizeRx Corporation (NASDAQ:OPRX) is a favorite amongst the big guns (Simply Wall St.)
Jan-05-23 06:01AM	Strength Seen in OptimizeRx Corp. (OPRX): Can Its 10.1% Jump Turn into More Strength? (Zacks)
Jan-04-23 07:30AM	OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference (GlobeNewswire) +10.05%
Nov-28-22 09:31AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-14-22 10:44AM	Heres Why Artisan Partners Exited its Position in OptimizeRx Corporation (OPRX) (Insider Monkey)
Nov-10-22 05:58AM	OptimizeRx Third Quarter 2022 Earnings: EPS Beats Expectations (Simply Wall St.) +14.58%
Nov-08-22 05:35PM	OptimizeRx Corp. (OPRX) Tops Q3 Earnings Estimates (Zacks)
04:01PM	OptimizeRx Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-03-22 06:39AM	Investing in OptimizeRx (NASDAQ:OPRX) five years ago would have delivered you a 228% gain (Simply Wall St.)
Oct-24-22 03:53PM	Top 10 Small-Cap Stocks With Highest Upside Potential (Insider Monkey)
Oct-20-22 09:00AM	OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event (GlobeNewswire)
Oct-19-22 04:05PM	OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ET (GlobeNewswire)
Oct-11-22 08:00AM	OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE Solution (GlobeNewswire)
Sep-23-22 06:23AM	Is OptimizeRx Corporation (NASDAQ:OPRX) Potentially Undervalued? (Simply Wall St.)
Sep-20-22 08:00AM	OptimizeRx Extends Exclusive Partnership with ePrescribing Leader Therapy Brands (GlobeNewswire)
Sep-07-22 08:00AM	OptimizeRx to Participate in Upcoming September Conferences (GlobeNewswire)
Aug-23-22 09:18AM	OptimizeRx Reports Results of Flagship Evidence-Based Physician Engagement Program (GlobeNewswire)
Aug-19-22 06:19AM	Chief Commercial Officer Stephen Silvestro Just Bought A Handful Of Shares In OptimizeRx Corporation (NASDAQ:OPRX) (Simply Wall St.)
Aug-10-22 09:22AM	Macro Factors Behind OptimizeRx's Weaker Than Expected Q2 Earnings, Lowers Annual Guidance (Benzinga) -30.02%
12:31AM	OptimizeRx Corporation (OPRX) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-09-22 08:16PM	UPDATE OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense (GlobeNewswire) -6.43%
06:35PM	OptimizeRx Corp. (OPRX) Misses Q2 Earnings and Revenue Estimates (Zacks)
04:05PM	OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense (GlobeNewswire)
Aug-02-22 10:00AM	OptimizeRx Corp. (OPRX) Reports Next Week: What to Know Ahead of the Release (Zacks)
Jul-26-22 07:30AM	OptimizeRx Extends Omnichannel Reach With Cooler Screens Partnership (GlobeNewswire) +8.16%
Jul-25-22 10:13AM	Down More Than 50%: These 2 Strong Buy Stocks Are Trading at Rock-Bottom Prices (TipRanks)
Jul-21-22 07:30AM	OptimizeRx Sets Second Quarter Fiscal 2022 Conference Call for Tuesday, August 9 at 4:30 p.m. ET (GlobeNewswire)
Jul-15-22 03:10PM	SVB Leerink Sees 'Cheaper Way' To Pharma Digital Marketing With This Stock (Benzinga) +5.08%
Jun-27-22 10:52AM	OptimizeRx Corp. (OPRX) Moves 8.9% Higher: Will This Strength Last? (Zacks)
Jun-23-22 07:30AM	OptimizeRx Brings Real-World Evidence-Driven Engagement Programs to Social Media With New Exclusive Partnership (GlobeNewswire)
Jun-16-22 12:27PM	5 Small-Cap Stocks That Are Diamonds in the Rough (InvestorPlace)
Jun-07-22 08:00AM	OptimizeRx Completes Platform Integration of TelaRep One-Click Prescriber Connectivity Solution (GlobeNewswire)
May-24-22 08:00AM	OptimizeRx to Participate in Upcoming June Conferences (GlobeNewswire)
May-17-22 10:00AM	OptimizeRxs Mike Rousselle Named One of 2022 PM360 ELITE 100 (GlobeNewswire) +12.30%

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Silvestro Stephen L	Chief Commercial Officer	Mar 01 '24	Option Exercise	0.00	1,927	0	6,624	Mar 06 04:20 PM
Odence-Ford Marion	General Counsel and CCO	Mar 01 '24	Option Exercise	0.00	771	0	14,499	Mar 06 04:19 PM
Odence-Ford Marion	General Counsel and CCO	Feb 11 '24	Option Exercise	0.00	4,000	0	15,114	Feb 13 06:16 PM
FEBBO WILLIAM J	CEO	Jan 09 '24	Option Exercise	0.00	9,628	0	481,028	Jan 18 05:56 PM
Odence-Ford Marion	General Counsel and CCO	Jan 09 '24	Sale	15.19	4,000	60,751	11,114	Jan 11 05:06 PM
Odence-Ford Marion	General Counsel and CCO	Nov 08 '23	Option Exercise	0.00	1,785	0	15,638	Nov 13 02:32 PM
Stelmakh Edward	CFO/COO	Oct 11 '23	Option Exercise	0.00	6,155	0	31,603	Oct 12 02:18 PM
Silvestro Stephen L	Chief Commercial Officer	Oct 03 '23	Option Exercise	0.00	6,649	0	6,649	Oct 06 02:47 PM
Odence-Ford Marion	General Counsel and CCO	Oct 03 '23	Option Exercise	0.00	6,649	0	15,805	Oct 06 02:47 PM
Besch Doug	Chief Product Officer	Oct 03 '23	Option Exercise	0.00	3,324	0	4,824	Oct 06 02:47 PM
Stelmakh Edward	CFO/COO	Oct 03 '23	Option Exercise	0.00	16,662	0	21,344	Oct 06 02:47 PM
HALAS GUS D	Director	Jun 07 '23	Option Exercise	0.00	4,637	0	70,865	Aug 18 10:03 AM
Spangler Patrick D	Director	Jun 07 '23	Option Exercise	0.00	4,637	0	22,120	Aug 18 09:33 AM
Lang James Paul	Director	Jun 07 '23	Option Exercise	0.00	4,637	0	44,697	Aug 18 09:31 AM
Vos Ellen O'Connor	Director	Jun 07 '23	Option Exercise	0.00	4,637	0	39,427	Aug 18 09:29 AM
WASSON GREGORY D	Director	Jun 07 '23	Option Exercise	0.00	4,637	0	23,968	Aug 18 09:28 AM

Open in Screener

AUGX

Augmedix Inc

May 02 • 04:00PM ET

2.66

Dollar change +0.13
Percentage change 5.14	%

Healthcare • Health Information Services • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF WISE IWC

Index	-	P/E	-	EPS (ttm)	-0.44	Insider Own	10.23%	Shs Outstand	48.61M	Perf Week	-4.66%
Market Cap	130.26M	Forward P/E	-	EPS next Y	-0.34	Insider Trans	27.11%	Shs Float	43.96M	Perf Month	-36.36%
Income	-19.17M	PEG	-	EPS next Q	-0.13	Inst Own	74.98%	Short Float	2.82%	Perf Quarter	-41.02%
Sales	44.85M	P/S	2.90	EPS this Y	-13.64%	Inst Trans	0.68%	Short Ratio	3.30	Perf Half Y	-39.55%
Book/sh	0.48	P/B	5.54	EPS next Y	32.50%	ROA	-38.21%	Short Interest	1.24M	Perf Year	-7.96%
Cash/sh	0.95	P/C	2.81	EPS next 5Y	-	ROE	-154.68%	52W Range	2.50 - 6.25	Perf YTD	-54.53%
Dividend Est.	-	P/FCF	-	EPS past 5Y	62.58%	ROI	-44.92%	52W High	-57.44%	Beta	0.53
Dividend TTM	-	Quick Ratio	2.41	Sales past 5Y	33.97%	Gross Margin	47.99%	52W Low	6.40%	ATR (14)	0.23
Dividend Ex-Date	-	Current Ratio	2.41	EPS Y/Y TTM	32.17%	Oper. Margin	-41.86%	RSI (14)	28.15	Volatility	6.35% 7.13%
Employees	1430	Debt/Eq	1.11	Sales Y/Y TTM	45.01%	Profit Margin	-42.74%	Recom	1.00	Target Price	6.10
Option/Short	Yes / Yes	LT Debt/Eq	0.83	EPS Q/Q	38.77%	Payout	-	Rel Volume	0.99	Prev Close	2.53
Sales Surprise	1.77%	EPS Surprise	7.69%	Sales Q/Q	44.90%	Earnings	Mar 18 AMC	Avg Volume	374.59K	Price	2.66
SMA20	-20.23%	SMA50	-28.80%	SMA200	-42.94%	Trades		Volume	369,538	Change	5.14%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-03-24	Resumed	B. Riley Securities	Buy	$5.50
Dec-15-23	Initiated	Evercore ISI	In-line	$6

Today 07:00AM	Augmedix to Participate in Upcoming Investor Conferences in May and June 2024 (GlobeNewswire)
Apr-30-24 07:00AM	Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024 (GlobeNewswire)
Apr-25-24 04:05PM	Augmedix Awarded on Newsweek's World's Best Digital Health Companies 2024 List (GlobeNewswire)
Apr-24-24 07:00AM	Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments (GlobeNewswire)
Apr-19-24 06:00AM	3 Penny Stocks That Could Make a Big Comeback by the End of Q2 (InvestorPlace)
02:05AM	Loading…
Apr-12-24 02:05AM	Insider Sell: Augmedix Inc's (AUGX) Chief Strategy Officer Ian Shakil Sells 92,787 Shares (GuruFocus.com)
Apr-10-24 01:51AM	Augmedix Inc (AUGX) Chief Strategy Officer Ian Shakil Sells 89,167 Shares (GuruFocus.com) -5.17%
Apr-09-24 07:00AM	Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care (GlobeNewswire)
Apr-05-24 02:42AM	Augmedix Inc (AUGX) Chief Strategy Officer Ian Shakil Sells 109,961 Shares (GuruFocus.com)
Apr-04-24 07:00AM	Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide (GlobeNewswire)
01:56AM	Augmedix Inc (AUGX) Chief Strategy Officer Ian Shakil Sells 97,441 Shares (GuruFocus.com)
Apr-02-24 08:35AM	Should You Invest in Augmedix (AUGX)? (Insider Monkey)
Mar-20-24 10:13AM	Augmedix, Inc. (NASDAQ:AUGX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-19-24 06:41AM	Q4 2023 Augmedix Inc Earnings Call (Thomson Reuters StreetEvents) +18.92%
Mar-18-24 08:53PM	AUGX Stock Earnings: Augmedix Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
05:31PM	Loading…
05:31PM	Augmedix Inc (AUGX) Reports Strong Revenue Growth and Margin Expansion in Q4 and Full Year 2023 (GuruFocus.com)
04:01PM	Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023 (GlobeNewswire)
Mar-14-24 07:04AM	10 Stocks George Soros and Insiders Are Crazy About (Insider Monkey)
Mar-12-24 07:00AM	Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go (GlobeNewswire)
Mar-08-24 07:00AM	Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 (GlobeNewswire)
Feb-27-24 07:00AM	Augmedix to Participate in Citizens JMP Technology Conference (GlobeNewswire)
Feb-13-24 07:00AM	Augmedix Names Tomer Levy as New Senior Vice President of Engineering (GlobeNewswire)
Jan-22-24 04:15PM	Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET (GlobeNewswire)
Jan-16-24 07:00AM	Augmedix Announces Participation in Maxim Group Virtual Healthcare IT Investor Conference (GlobeNewswire)
Jan-05-24 08:00AM	Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue (GlobeNewswire)
Dec-22-23 07:00AM	7 Micro-Cap Stocks for Risk-Tolerant Investors to Buy in 2024 (InvestorPlace)
Dec-13-23 10:29AM	Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation (PR Newswire)
Nov-21-23 07:00AM	Augmedix Announces Closing of Public Offering of Common Stock, Including Additional Investments from HCA Healthcare and Redmile Group (GlobeNewswire)
Nov-16-23 08:51AM	Why Is Augmedix (AUGX) Stock Down 27% Today? (InvestorPlace) -17.31%
12:15AM	Augmedix Announces Pricing of Upsized Public Offering of 6,250,000 Shares of Common Stock (GlobeNewswire)
04:02PM	Loading…
Nov-15-23 04:02PM	Augmedix Announces Proposed Public Offering of 5,500,000 Shares of Common Stock (GlobeNewswire)
Nov-10-23 09:55AM	How Much Upside is Left in Augmedix, Inc. (AUGX)? Wall Street Analysts Think 36.67% (Zacks)
08:50AM	Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Nov-07-23 09:55AM	Augmedix, Inc. (NASDAQ:AUGX) Q3 2023 Earnings Call Transcript (Insider Monkey) +13.19%
Nov-06-23 05:10PM	Augmedix Inc (AUGX) Reports 50% Revenue Growth and Expanded Gross Margins in Q3 2023 (GuruFocus.com) -6.57%
04:02PM	Augmedix Delivers 50% Revenue Growth and Expanded Gross Margins for Third Quarter of 2023 (GlobeNewswire)
Oct-30-23 07:00AM	Augmedix to Announce Third Quarter 2023 Financial Results and Host Investor Conference Call on November 6, 2023 (GlobeNewswire)
Oct-20-23 08:02AM	Definitive Healthcare Corp. (DH) Soars 7.1%: Is Further Upside Left in the Stock? (Zacks) -5.02%
Oct-12-23 07:59AM	Augmedix, Inc. (AUGX) Soars 7.6%: Is Further Upside Left in the Stock? (Zacks) -7.37%
Oct-09-23 08:50AM	Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Oct-05-23 07:15AM	Ellipsis Health and Augmedix to Partner to Bring Automated Mental Health Screenings to Patient Visits (PR Newswire)
07:00AM	Augmedix Forging Strategic Partnerships for an Open Network of Digital Health Solutions (GlobeNewswire)
Sep-27-23 07:00AM	Augmedix Announces New AI Medical Documentation Product, Augmedix Go, a Clinician-Controlled Mobile App (GlobeNewswire)
Sep-25-23 07:54AM	Zacks.com featured highlights include Lifeway Foods, Augmedix and Clearwater Analytics (Zacks)
Sep-22-23 06:39AM	3 Best Breakout Stocks to Buy Now for Solid Returns (Zacks)
Sep-21-23 08:50AM	Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
07:00AM	Augmedix Announces Inaugural AI Advisory Council Members (GlobeNewswire)
Sep-20-23 07:22AM	Zacks Industry Outlook Highlights P3 Health Partners, Talkspace and Augmedix (Zacks)
Sep-12-23 09:40AM	Are Medical Stocks Lagging Augmedix (AUGX) This Year? (Zacks)
Sep-06-23 07:00AM	Augmedix Announces Expanding Coverage in Behavioral Health Field for Acute and Ambulatory Care Settings (GlobeNewswire)
Sep-05-23 08:50AM	Recent Price Trend in Augmedix, Inc. (AUGX) is Your Friend, Here's Why (Zacks)
Sep-04-23 09:55AM	Can Augmedix, Inc. (AUGX) Climb 36.06% to Reach the Level Wall Street Analysts Expect? (Zacks)
Aug-24-23 09:40AM	Is Artivion (AORT) Outperforming Other Medical Stocks This Year? (Zacks) -9.23%
07:00AM	Augmedix Achieves HITRUST Certification to Further Mitigate Risk in Third-Party Privacy, Security and Compliance (GlobeNewswire)
Aug-18-23 07:00AM	Augmedix Announces Participation in Upcoming Investor Conferences in September 2023 (GlobeNewswire) +6.91%
Aug-16-23 09:55AM	Wall Street Analysts See a 32.11% Upside in Augmedix, Inc. (AUGX): Can the Stock Really Move This High? (Zacks)
08:50AM	Augmedix, Inc. (AUGX) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Aug-09-23 09:25AM	Augmedix, Inc. (NASDAQ:AUGX) Q2 2023 Earnings Call Transcript (Insider Monkey) -5.54%
Aug-08-23 03:27PM	Why Shares of Augmedix Are Climbing on Tuesday (Motley Fool) +19.66%
Aug-07-23 05:50PM	Augmedix, Inc. (AUGX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:02PM	Augmedix Delivers 47% Revenue Growth and Expanded Gross Margins for Second Quarter of 2023 (GlobeNewswire)
Jul-28-23 07:00AM	Augmedix to Announce Second Quarter 2023 Financial Results and Host Investor Conference Call on August 7, 2023 (GlobeNewswire)
Jul-12-23 08:29AM	Oceania Cruises Curates a Collection of Enticing Mediterranean Sojourns Sailing to Cosmopolitan Cities and Undiscovered Gems (PR Newswire)
Jul-10-23 08:42AM	Zacks Industry Outlook Highlights Definitive Healthcare, Clover Health and Augmedix (Zacks) -7.68%
Jul-07-23 11:04AM	3 Medical Info Systems Stocks to Consider From a Prospering Industry (Zacks)
Jun-29-23 08:50AM	Here's Why Momentum in Augmedix, Inc. (AUGX) Should Keep going (Zacks)
Jun-16-23 09:40AM	Is Augmedix (AUGX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jun-14-23 07:05AM	Augmedix Extends Term Loan Facility and Finalizes Terms for Equity Line of Credit (GlobeNewswire)
Jun-12-23 07:00AM	Augmedix Establishes AI Advisory Council to Guide the Companys Continued Development of High Standard, Responsible Product Development (GlobeNewswire) +9.20%
May-31-23 09:40AM	Is Augmedix (AUGX) Outperforming Other Medical Stocks This Year? (Zacks)
May-19-23 08:24AM	Augmedix Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
May-12-23 08:15AM	Augmedix, Inc. (AUGX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -19.14%
07:00AM	Augmedix Delivers Continued Sales Momentum; Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-08-23 07:00AM	Augmedix to Announce First Quarter 2023 Financial Results and Host Investor Conference Call on May 12, 2023 (GlobeNewswire)
May-05-23 01:34PM	3 Must-Watch Wearable Tech Stocks as the Industry Booms (InvestorPlace) +15.62%
Apr-28-23 06:47PM	Dlocal, Augmedix See Activist Investor Action (Barrons.com)
06:47PM	Dlocal and Augmedix Stock See Action From Activist Investors (Barrons.com)
Apr-20-23 06:31AM	Augmedix Announces Partnership with HCA Healthcare to Accelerate the Development of AI-enabled Ambient Documentation (GlobeNewswire) +88.89%
06:30AM	Augmedix Secures Strategic Financing from HCA Healthcare and Redmile Group (GlobeNewswire)
Mar-29-23 07:27AM	Augmedix, Inc. (NASDAQ:AUGX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-27-23 07:00AM	Augmedix Reports Strong Commercial Traction and Sales Momentum; Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) +14.67%
Mar-16-23 07:00AM	Augmedix to Announce Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call on March 27, 2023 (GlobeNewswire)
Mar-07-23 07:00AM	Augmedix Announces Participation in Oppenheimers 33rd Annual Healthcare Conference (GlobeNewswire)
Mar-01-23 08:00AM	Augmedix Names Rod OReilly as Non-Executive Chairman of the Board of Directors (GlobeNewswire)
Feb-16-23 07:00AM	Augmedix Announces Participation in Winter Wonderland Best Ideas Investor Conference (GlobeNewswire)
Jan-18-23 04:05PM	Augmedix Announces Participation in Maxim Group Healthcare IT Investor Conference on January 25 (GlobeNewswire)
Jan-09-23 07:00AM	Augmedix Exits Calendar 2022 with Expected $35 Million in Annual Recurring Revenue (GlobeNewswire)
Dec-25-22 12:07PM	Augmedix, Inc. (NASDAQ:AUGX) Q3 2022 Earnings Call Transcript (Insider Monkey)
Nov-23-22 04:05PM	Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference (GlobeNewswire) +6.25%
Nov-16-22 08:00AM	Augmedix Announces Partnership with Veterinary Specialty Center to Support Emergency Veterinary and Specialty Care (GlobeNewswire) -8.82%
Nov-14-22 04:05PM	Augmedix Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-07-22 08:00AM	Augmedix to Report Third Quarter 2022 Financial Results on November 14, 2022 (GlobeNewswire) -5.26%
Oct-04-22 08:00AM	Augmedix Partners with Kirby Medical Center to Significantly Reduce Documentation Burden for Physicians and Improve Patient Experiences (GlobeNewswire) -8.57%
Sep-15-22 04:05PM	Augmedix to Participate at the 2022 Lytham Partners Fall Investor Conference (GlobeNewswire) +16.34%
Sep-06-22 04:05PM	Augmedix Launches New Service, Augmedix Prep, to Significantly Reduce Physician Chart Prep Burden (GlobeNewswire) +7.06%
Aug-30-22 04:05PM	Augmedix to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire) +15.62%
Aug-17-22 04:05PM	Augmedix to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase (GlobeNewswire)
Aug-08-22 04:05PM	Augmedix Reports Second Quarter 2022 Financial Results (GlobeNewswire)
04:01PM	Augmedix Announces Expanded Partnership with Adventist Health (GlobeNewswire)
Aug-03-22 08:00AM	Augmedix - Trio Health - CIIC First of its Kind Real-World Patient Ecosystem - Standardizing Relevant Clinical Data at the Point of Care (GlobeNewswire)

Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. It offers live support including referrals, orders, and reminders that allow clinicians to focus on patient care. The company was founded by Ian Shakil in 2012 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 15 '24	Option Exercise	0.86	500	430	3,500	Apr 16 09:07 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 15 '24	Sale	3.80	500	1,900	3,000	Apr 16 09:07 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 12 '24	Option Exercise	0.86	19,544	16,808	22,544	Apr 15 09:15 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 12 '24	Sale	3.82	19,544	74,590	3,000	Apr 15 09:15 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 11 '24	Option Exercise	0.86	24,778	21,309	27,778	Apr 11 08:30 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 11 '24	Sale	3.93	24,778	97,477	3,000	Apr 11 08:30 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 10 '24	Option Exercise	0.86	36,467	31,362	39,467	Apr 11 08:30 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 10 '24	Sale	3.87	36,467	141,288	3,000	Apr 11 08:30 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 09 '24	Option Exercise	0.76	31,542	23,968	34,542	Apr 11 08:30 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 09 '24	Sale	4.14	31,542	130,521	3,000	Apr 11 08:30 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 08 '24	Option Exercise	0.64	28,563	18,280	40,780	Apr 09 08:49 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 08 '24	Sale	3.97	37,780	149,968	3,000	Apr 09 08:49 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 05 '24	Sale	4.03	51,387	207,233	12,217	Apr 09 08:49 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 04 '24	Sale	4.15	64,055	265,854	31,610	Apr 04 08:30 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 03 '24	Sale	4.11	45,906	188,600	95,665	Apr 04 08:30 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 02 '24	Sale	3.89	38,463	149,725	141,571	Apr 03 09:30 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 01 '24	Option Exercise	0.64	51,346	32,861	239,012	Apr 03 09:30 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Apr 01 '24	Sale	3.91	58,978	230,384	180,034	Apr 03 09:30 PM
Shakil Ian	CHIEF STRATEGY OFFICER	Mar 28 '24	Sale	4.06	31,994	129,851	187,666	Apr 01 08:28 PM
Ginocchio Paul	CHIEF FINANCIAL OFFICER	Nov 22 '23	Buy	4.85	10,000	48,500	128,000	Nov 27 07:00 AM
Redmile Group, LLC	Director	Nov 20 '23	Buy	4.00	750,000	3,000,000	16,404,017	Nov 22 04:15 PM
Redmile Group, LLC	Director	Nov 20 '23	Buy	4.00	750,000	3,000,000	9,446,146	Nov 22 04:15 PM
Traylor Margie L.	Director	Jun 14 '23	Buy	4.51	26,530	119,649	47,331	Jun 16 05:50 PM
Traylor Margie L.	Director	May 15 '23	Option Exercise	2.20	10,182	22,400	20,801	May 17 07:00 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

OPRX

OptimizeRx Corp

AUGX

Augmedix Inc

Upgrade your FINVIZ experience